170 related articles for article (PubMed ID: 11606078)
1. Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer.
Schindl M; Birner P; Breitenecker G; Oberhuber G
Gynecol Oncol; 2001 Nov; 83(2):244-8. PubMed ID: 11606078
[TBL] [Abstract][Full Text] [Related]
2. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
[TBL] [Abstract][Full Text] [Related]
3. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumor angiogenesis, and survival in platinum-treated patients.
Alvarez AA; Axelrod JR; Whitaker RS; Isner PD; Bentley RC; Dodge RK; Rodriguez GC
Gynecol Oncol; 2001 Aug; 82(2):273-8. PubMed ID: 11531279
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression.
Jackson P; Ow K; Yardley G; Delprado W; Quinn DI; Yang JL; Russell PJ
Prostate Cancer Prostatic Dis; 2003; 6(2):174-81. PubMed ID: 12806379
[TBL] [Abstract][Full Text] [Related]
6. KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer.
Muneyuki T; Watanabe M; Yamanaka M; Shiraishi T; Isaji S
Anticancer Res; 2001; 21(5):3581-7. PubMed ID: 11848527
[TBL] [Abstract][Full Text] [Related]
7. KAI1 protein is down-regulated during the progression of human breast cancer.
Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M
Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
[TBL] [Abstract][Full Text] [Related]
8. Loss of KAI1 expression in the progression of colorectal cancer.
Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival.
Farhadieh RD; Smee R; Ow K; Yang JL; Russell PJ; Crouch R; Jackson P; Jacobson IV
Cancer Lett; 2004 Sep; 213(1):91-8. PubMed ID: 15312688
[TBL] [Abstract][Full Text] [Related]
10. Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer.
Ow K; Delprado W; Fisher R; Barrett J; Yu Y; Jackson P; Russell PJ
J Pathol; 2000 May; 191(1):39-47. PubMed ID: 10767717
[TBL] [Abstract][Full Text] [Related]
11. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
[TBL] [Abstract][Full Text] [Related]
13. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer.
Eltabbakh GH; Belinson JL; Kennedy AW; Biscotti CV; Casey G; Tubbs RR; Blumenson LE
Cancer; 1997 Sep; 80(5):892-8. PubMed ID: 9307189
[TBL] [Abstract][Full Text] [Related]
14. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines.
White A; Lamb PW; Barrett JC
Oncogene; 1998 Jun; 16(24):3143-9. PubMed ID: 9671393
[TBL] [Abstract][Full Text] [Related]
15. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases.
Guo X; Friess H; Graber HU; Kashiwagi M; Zimmermann A; Korc M; Büchler MW
Cancer Res; 1996 Nov; 56(21):4876-80. PubMed ID: 8895737
[TBL] [Abstract][Full Text] [Related]
16. Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer.
Yang JL; Jackson P; Yu Y; Russell PJ; Markovic B; Crowe PJ
Anticancer Res; 2002; 22(6A):3337-42. PubMed ID: 12530084
[TBL] [Abstract][Full Text] [Related]
17. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma.
Guo XZ; Friess H; Di Mola FF; Heinicke JM; Abou-Shady M; Graber HU; Baer HU; Zimmermann A; Korc M; Büchler MW
Hepatology; 1998 Dec; 28(6):1481-8. PubMed ID: 9828210
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.
Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT
Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131
[TBL] [Abstract][Full Text] [Related]
19. Loss of KAI1 expression in gastric cancer.
Tsutsumi S; Shimura T; Morinaga N; Mochiki E; Asao T; Kuwano H
Hepatogastroenterology; 2005; 52(61):281-4. PubMed ID: 15783050
[TBL] [Abstract][Full Text] [Related]
20. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
